Viking Therapeutics, Inc. (VKTX) stock
VKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$26.17−0.71 (-2.64%)
Close on Nov 18, 2026Market cap $3.34BP/E –Yield –
Viking Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Viking Therapeutics's market cap was $3.32B on Nov 11, 2026, against $4.14B a year earlier. Over the last 5 years it ranged from $171.77M to $8.21B, with a median of $3.04B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.32B | -16.1% |
| 2025 | Dec 31, 2025 | $3.96B | -11.8% |
| 2024 | Dec 31, 2024 | $4.48B | +140.9% |
| 2023 | Dec 29, 2023 | $1.86B | +158.2% |
| 2022 | Dec 30, 2022 | $720.87M | +100.3% |
| 2021 | Dec 31, 2021 | $359.88M | -12.3% |
| 2020 | Dec 31, 2020 | $410.55M | -29.2% |
| 2019 | Dec 31, 2019 | $579.49M | +6.3% |
| 2018 | Dec 31, 2018 | $545.33M | +371.3% |
| 2017 | Dec 29, 2017 | $115.71M | +388.7% |
| 2016 | Dec 30, 2016 | $23.68M | -29.0% |
| 2015 | Dec 31, 2015 | $33.36M | – |
See a number that looks wrong?